| Patent | Date |
|---|
Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
Grant 9,980,903 - Berner , et al. May 29, 2 | 2018-05-29 |
Shell-and-core Dosage Form Approaching Zero-order Drug Release
App 20130164377 - Berner; Bret ; et al. | 2013-06-27 |
Gastric Retentive Oral Dosage Form With Restricted Drug Release In The Lower Gastrointestinal Tract
App 20130149379 - Berner; Bret ; et al. | 2013-06-13 |
Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
Grant 7,976,870 - Berner , et al. July 12, 2 | 2011-07-12 |
Pharmacological inducement of the fed mode for enhanced drug administration to the stomach
Grant 7,405,238 - Markey , et al. July 29, 2 | 2008-07-29 |
Extending the duration of drug release within the stomach during the fed mode
Grant 6,635,280 - Shell , et al. October 21, 2 | 2003-10-21 |
Pharmacological inducement of the fed mode for enhanced drug administration to the stomach
App 20030044466 - Markey, Micheline ; et al. | 2003-03-06 |
Extending the duration of drug release within the stomach during the fed mode
App 20030039688 - Shell, John W. ; et al. | 2003-02-27 |
Method for identifying compounds to treat medical pathologies associated with molecular crystallization
App 20020132758 - Shell, John W. | 2002-09-19 |
Extending the duration of drug release within the stomach during the fed mode
App 20020051820 - Shell, John W. ; et al. | 2002-05-02 |
Extending the duration of drug release within the stomach during the fed mode
Grant 6,340,475 - Shell , et al. January 22, 2 | 2002-01-22 |
Extending The Duration Of Drug Release Within The Stomach During The Fed Mode
App 20010018070 - SHELL, JOHN W. ; et al. | 2001-08-30 |
Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter
Grant 5,972,389 - Shell , et al. October 26, 1 | 1999-10-26 |
Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
Grant 5,582,837 - Shell December 10, 1 | 1996-12-10 |
Sustained-release oral drug dosage form
Grant 5,007,790 - Shell April 16, 1 | 1991-04-16 |
Ocular preparation housing steroid in two different therapeutic forms
Grant 4,478,818 - Shell , et al. October 23, 1 | 1984-10-23 |
Topical composition containing steroid in two forms released independently from polymeric carrier
Grant 4,432,964 - Shell , et al. * February 21, 1 | 1984-02-21 |
Ocular insert housing steroid in two different therapeutic forms
Grant 4,304,765 - Shell , et al. December 8, 1 | 1981-12-08 |
Medication indicated for ocular hypertension
Grant 4,303,637 - Shell , et al. December 1, 1 | 1981-12-01 |
Drug delivery system for controlled ocular therapy
Grant 4,281,654 - Shell , et al. August 4, 1 | 1981-08-04 |
Ocular system made of bioerodible esters having linear ether
Grant 4,115,544 - Shell September 19, 1 | 1978-09-19 |
Ophthalmological bioerodible drug dispensing formulation
Grant 4,001,388 - Shell January 4, 1 | 1977-01-04 |
Ocular insert
Grant 3,995,635 - Higuchi , et al. December 7, 1 | 1976-12-07 |
Bioerodible ocular device
Grant 3,993,071 - Higuchi , et al. November 23, 1 | 1976-11-23 |
Bioerodible ocular device
Grant 3,986,510 - Higuchi , et al. October 19, 1 | 1976-10-19 |
Bioerodible ocular device
Grant 3,981,303 - Higuchi , et al. September 21, 1 | 1976-09-21 |
Bioerodible ocular device
Grant 3,960,150 - Hussain , et al. June 1, 1 | 1976-06-01 |
Ophthalmic dosage form, for releasing medication over time
Grant 3,914,402 - Shell October 21, 1 | 1975-10-21 |
| 